Related Experiment Video
Updated: May 23, 2026
26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Current therapies and future perspectives in subacute sclerosing panencephalitis
Burak Tatli1, Bariş Ekici, Meral Ozmen
1Department of Pediatric Neurology, Istanbul Medical Faculty, Istanbul, Turkey.
Expert Review of Neurotherapeutics
|March 28, 2012
Summary
Subacute sclerosing panencephalitis (SSPE) therapies show potential in slowing disease progression and improving life expectancy. However, long-term outcomes and effectiveness in rapidly progressive cases remain uncertain, with future treatments in early research.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Subacute sclerosing panencephalitis (SSPE) is a severe, progressive neurological disorder.
- It is caused by a persistent, defective measles virus infection in the host.
- SSPE primarily affects children and young adults.
Purpose of the Study:
- To review the current therapeutic strategies for SSPE.
- To evaluate the efficacy and limitations of existing treatments.
- To explore potential future therapeutic avenues for SSPE.
Main Methods:
- Review of clinical trial results for antiviral and immunomodulatory therapies.
- Analysis of studies on the long-term effects and outcomes of SSPE treatment.
- Examination of emerging experimental therapies such as RNA interference (RNAi) and antiapoptotic agents.
Main Results:
- Antiviral and/or immunomodulatory therapies can slow SSPE progression and improve life expectancy.
- Conflicting results exist regarding the long-term benefits and eventual outcome of current therapies.
- Current treatments show limited efficacy in the rapidly progressive form of SSPE.
Conclusions:
- Current therapies offer some benefit but do not provide a definitive cure for SSPE.
- The long-term efficacy and ultimate outcome of SSPE treatment remain subjects of debate.
- RNAi and antiapoptotic agents represent promising, albeit experimental, future therapeutic options for SSPE.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...